• Golden Sun Health Technology received Nasdaq notice dated April 13, 2026 for failing to maintain minimum bid price of US$1 over 30 consecutive business days.
• Nasdaq set compliance deadline of Oct. 12, 2026 to regain Listing Rule 5550(a)(2) status.
• Shares must close at or above US$1 for at least 10 consecutive business days to cure deficiency.
• Failure to regain compliance by deadline could trigger delisting notice, with option to appeal to Nasdaq panel.
• Golden Sun may consider reverse stock split to restore compliance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Golden Sun Health Technology Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-044632), on April 16, 2026, and is solely responsible for the information contained therein.